about
Breast cancer with neoductgenesis: histopathological criteria and its correlation with mammographic and tumour features.The Nordic SentiMag trial: a comparison of super paramagnetic iron oxide (SPIO) nanoparticles versus Tc(99) and patent blue in the detection of sentinel node (SN) in patients with breast cancer and a meta-analysis of earlier studies.Ductal Breast Carcinoma In Situ: Mammographic Features and Its Relation to Prognosis and Tumour Biology in a Population Based Cohort.Risk of death from breast cancer after treatment for ductal carcinoma in situ.Simplifying Logistics and Avoiding the Unnecessary in Patients with Breast Cancer Undergoing Sentinel Node Biopsy. A Prospective Feasibility Trial of the Preoperative Injection of Super Paramagnetic Iron Oxide Nanoparticles.Superparamagnetic iron oxide nanoparticles as the sole method for sentinel node biopsy detection in patients with breast cancer.High experienced continuity in breast cancer care is associated with high health related quality of life.Meta-analysis of neoadjuvant therapy and its impact in facilitating breast conservation in operable breast cancerA combined, totally magnetic technique with a magnetic marker for non-palpable tumour localization and superparamagnetic iron oxide nanoparticles for sentinel lymph node detection in breast cancer surgeryEffect of radiotherapy after breast-conserving surgery for ductal carcinoma in situ: 20 years follow-up in the randomized SweDCIS TrialOptimisation of breast MRI compatibility after sentinel node biopsy with paramagnetic tracersTime from breast cancer diagnosis to therapeutic surgery and breast cancer prognosis: A population-based cohort studyRisk of ischemic heart disease after radiotherapy for ductal carcinoma in situSurvival and risk of breast cancer recurrence after breast reconstruction with deep inferior epigastric perforator flapNot all artifacts after magnetic guided sentinel lymph node biopsy are necessarily related to superparamagnetic iron oxide nanoparticlesA Biological Signature for Breast Ductal Carcinoma In Situ to Predict Radiotherapy Benefit and Assess Recurrence RiskImpact of Epithelial-Stromal Interactions on Peritumoral Fibroblasts in Ductal Carcinoma in SituEffect of preoperative injection of superparamagnetic iron oxide particles on rates of sentinel lymph node dissection in women undergoing surgery for ductal carcinoma in situ (SentiNot study)Cross comparison and prognostic assessment of breast cancer multigene signatures in a large population-based contemporary clinical seriesASO Author Reflections: SPIO, a New Sentinel Node Tracer with Interesting Future Clinical Applications
P50
Q34454213-23DD4166-4772-4D4E-A1BE-05311D4F8218Q36922539-FEE4D312-4074-4AC4-8122-9E00001772AAQ37670843-B8D4ABDC-BCD6-416E-8642-99F922D22461Q40073925-978BF1D7-5EC4-47EF-9941-F1D138E47655Q47219090-F4933FD0-DDD2-4C0F-9503-AA3C7363FEFBQ47848267-9C4DB30F-FD73-4040-8516-1594B5B6C905Q49843557-2192C8B8-2BEB-4018-859A-0574C0753A00Q57113772-B6A513FA-AFCA-4921-B981-73B7C786A9F6Q58571568-2B31B4DC-2DCB-412C-AFE1-8EAB15232BF1Q85774315-A25E5096-437B-419F-9732-94F31A33CB75Q87873124-3789230F-D619-467E-BDFD-F82B69AD7EACQ88231941-E7618FBE-057A-430C-BCB5-D1384D085A0AQ88580715-3C3EFC52-4907-4BA7-96B3-670A8D18F6FBQ89589754-497FDB33-4DD4-4CEA-BB5B-8BF72A5DAFDFQ89993310-12C3DEF2-409E-4A94-9D00-640E2D9E017DQ90579020-ECAD5F69-68EB-4BEB-BAB9-2F938897A187Q92001842-A4C1EA9E-7EE1-4C77-891A-12B36BCAC5C9Q92156789-B910AA9C-B758-43BC-BC26-DCD3A53A57F5Q92757405-F1CB8D8D-D18B-4226-8598-53BA4D895ACBQ92829020-DE5B8366-FEEB-4809-AFA3-23DB3C5390F0
P50
description
researcher (ORCID 0000-0002-6274-2435)
@en
name
Fredrik Wärnberg
@en
type
label
Fredrik Wärnberg
@en
prefLabel
Fredrik Wärnberg
@en
P31
P496
0000-0002-6274-2435